Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Zoning regulations impact where marijuana dispensaries can locate

  • Hatha yoga boosts brain function in older adults, study suggests

  • Rheumatologic diseases like lupus can initially look like neurological disorders

  • Are children who play violent video games at greater risk for depression?

  • Fighting unfairness: Children have advanced ideas about fairness

  • Studies promoting use of antidepressants for postoperative pain may be premature, review finds

  • Dyslexia: Balanced view needed on expensive lenses to improve reading

  • Growing up poor affects adults' sense of control, impulsiveness when faced with economic uncertainty

  • Targeted brain training may help you multitask better

  • Why elderly are prone to sleep problems

  •